Related Experiment Video
Updated: May 5, 2026

Bacterial Detection & Identification Using Electrochemical Sensors
Published on: April 23, 2013
Disparities in Urine Testing Among Febrile Children in US Emergency Departments
Than S Kyaw1, Carina De La Cueva2, Natalia Leva2
1Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA.
Insights
Racial and ethnic disparities in urine testing for febrile children in emergency departments have decreased. Initially, Hispanic and Black females received fewer urine tests, but by 2021, testing rates were equivalent across all groups.
Area of Science:
- Pediatrics
- Health Services Research
- Health Equity
Background:
- Urine testing is crucial for diagnosing infections in febrile children.
- Previous studies suggest racial and ethnic disparities in healthcare access and utilization.
Purpose of the Study:
- To assess racial and ethnic disparities in urine testing for febrile children in US emergency departments.
- To analyze trends in urine testing rates from 2002 to 2021.
Main Methods:
- Cross-sectional analysis of the National Hospital Ambulatory Medical Care Survey (NHAMCS) data.
- Inclusion of children aged 2-24 months with fever (≥38°C) presenting to emergency departments.
- Stratified analysis by sex, race, and ethnicity, with univariate and multivariate trend analyses.
Main Results:
- Over 31 million emergency department visits for febrile children were analyzed.
- In 2002-2012, Hispanic and non-Hispanic Black females had significantly lower urine testing rates compared to non-Hispanic White females.
- Urine testing rates increased significantly for Hispanic and non-Hispanic Black females over time, eliminating disparities by 2021. No disparities were observed among males.
Conclusions:
- Racial and ethnic disparities in urine testing for febrile children have diminished over two decades.
- Equivalency in urine testing rates was achieved for females across racial and ethnic groups by 2021.
- Further research is needed to investigate the impact of these trends on health outcome disparities.
Objective:
To evaluate the association of race and ethnicity with urine testing for febrile children in the emergency department and to measure trends in urine testing from 2002 to 2021.
Study Design/Methods:
We conducted a cross-sectional analysis of children aged 2-24 months with a recorded temperature of ≥ 38 °C who presented to an emergency department in the United States from 2002 to 2021 using the National Hospital Ambulatory Medical Care Survey. We assessed trends in urine testing stratified by sex, race, and ethnicity over two decades and performed univariate and multivariate analyses.
Results:
Between 2002 and 2021, there were 31,552,201 estimated emergency department visits by febrile children aged 2-24 months with recorded temperature ≥ 38.0 °C. In 2002-2012, Hispanic females and non-Hispanic Black females had significantly lower frequencies (13-19% vs. 26%; p < 0.001) compared to non-Hispanic White females. However, urine testing frequencies significantly increased over the study period for Hispanic and non-Hispanic Black females (coefficients of 1.10 and 0.74, respectively; multivariate linear regression tests for trend, p < 0.05). By 2021, there were no racial and ethnic differences in urine testing (p > 0.05). There were no differences among males (p > 0.05).
Conclusions:
Nationally, Hispanic and non-Hispanic Black females had disproportionately lower frequencies of receiving urine tests at the beginning of the study period but had equivalent frequencies to non-Hispanic White females by 2021, suggesting that racial and ethnic disparities have decreased over time. Future research will examine the impact of these trends on disparities in health outcomes.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies I: Urinalysis
Urine Studies II: Urine Culture and Sensitivity Test

